Yang et al. identified that GC patients with higher SERPINE1 expression had shorter OS and it could promote the proliferation, invasion, and migration of GC cells, indicating that SERPINE1 might serve as a new therapeutic target for GC (51). Here, SERPINE1 is linked to gastric cancer.